The experience of bipolar disorder: a personal perspective on the impact of mood disorder symptoms

J Licinio - Molecular psychiatry, 2005 - nature.com
This is a personal perspective on bipolar disorder, entirely written by a well-informed patient
who is a successful mental heath professional. The patient prefers to remain anonymous; …

[HTML][HTML] Pharmacogenomics of mood stabilizers in the treatment of bipolar disorder

A Squassina, M Manchia… - Human genomics and …, 2010 - ncbi.nlm.nih.gov
Bipolar disorder (BD) is a chronic and often severe psychiatric illness characterized by
manic and depressive episodes. Among the most effective treatments, mood stabilizers …

Potential pharmacogenomic targets in bipolar disorder: considerations for current testing and the development of decision support tools to individualize treatment …

AB Cuéllar-Barboza, SL McElroy, M Veldic… - International Journal of …, 2020 - Springer
Background Treatment in bipolar disorder (BD) is commonly applied as a multimodal
therapy based on decision algorithms that lack an integrative understanding of molecular …

[HTML][HTML] Pharmacogenomic aspects of bipolar disorder: An update

M Budde, D Degner, J Brockmöller… - European …, 2017 - Elsevier
The hopes for readily implementable precision medicine are high. For many complex
disorders, such as bipolar disorder, these hopes critically hinge on tangible successes in …

Pharmacogenomics in the treatment of mood disorders: strategies and opportunities for personalized psychiatry

AT Amare, KO Schubert, BT Baune - EPMA journal, 2017 - Springer
Personalized medicine (personalized psychiatry in a specific setting) is a new model
towards individualized care, in which knowledge from genomics and other omic pillars …

Genetics of bipolar disorder

KS O'Connell, OB Smeland, OA Andreassen - Psychiatric Genomics, 2022 - Elsevier
Bipolar disorder is characterized by pathological mood episodes, both mania and
depression. A series of genetic studies have demonstrated a high degree of heritability and …

Pharmacogenomic characterization in bipolar spectrum disorders

S Fortinguerra, V Sorrenti, P Giusti, M Zusso, A Buriani - Pharmaceutics, 2019 - mdpi.com
The holistic approach of personalized medicine, merging clinical and molecular
characteristics to tailor the diagnostic and therapeutic path to each individual, is steadily …

Pharmacogenomics of bipolar disorder

G Severino, A Squassina, M Costa, C Pisanu… - …, 2013 - Taylor & Francis
Bipolar disorder (BD) is a lifelong severe psychiatric condition with high morbidity, disability
and excess mortality. The longitudinal clinical trajectory of BD is significantly modified by …

Genomic regulatory sequences in the pathogenesis of bipolar disorder

A Levchenko, M Plotnikova - Frontiers in Psychiatry, 2023 - frontiersin.org
The lifetime prevalence of bipolar disorder is estimated to be about 2%. Epigenetics defines
regulatory mechanisms that determine relatively stable patterns of gene expression by …

Identification of molecular mechanisms underlying mood stabilization through genome-wide gene expression profiling

R Zhou, CA Zarate Jr, HK Manji - International Journal of …, 2006 - academic.oup.com
Although Kraepelin described bipolar disorder (BD) to have a relatively good prognosis
(Kraepelin, 1921), more recent studies have clearly shown that this may only represent the …